Archer Pharmaceuticals will present at the 2018 San Diego Health Impact Forum its most recent advances in the development of drugs for the treatment of Alzheimer’s disease.  Dr. Mike Mullan will be presenting in one of the “Groundbreaking Discoveries and Innovations” sessions and will be describing his current clinical development program that slows the advance of Alzheimer’s disease which has increasing worldwide incidence and prevalence.